Using Artificial Intelligence to Better Predict and Develop Biomarkers.

Sam A Michelhaugh1, James L Januzzi2

  • 1Georgetown University School of Medicine, Washington, DC, USA.

Heart Failure Clinics
|March 28, 2022
PubMed
Summary

Technological advancements, including omics platforms and artificial intelligence (AI), are revolutionizing heart failure (HF) biomarker discovery. These tools enhance risk identification, patient monitoring, and therapeutic target development for improved HF care.